134 related articles for article (PubMed ID: 9887998)
1. Effects of zaprinast on renal nerve stimulation-induced anti-natriuresis in anaesthetized dogs.
Sekizawa T; Shima Y; Yoshida K; Tanahashi M; Yoshida M; Suzuki-Kusaba M; Hisa H; Satoh S
Clin Exp Pharmacol Physiol; 1998 Dec; 25(12):1008-12. PubMed ID: 9887998
[TBL] [Abstract][Full Text] [Related]
2. An intracellular calcium release inhibitor TMB-8 suppresses renal nerve stimulation-induced antinatriuresis in dogs.
Ogasawara A; Hisa H; Satoh S
J Pharmacol Exp Ther; 1993 Jan; 264(1):117-21. PubMed ID: 8423524
[TBL] [Abstract][Full Text] [Related]
3. Renal interstitial cGMP mediates natriuresis by direct tubule mechanism.
Jin XH; Siragy HM; Carey RM
Hypertension; 2001 Sep; 38(3):309-16. PubMed ID: 11566896
[TBL] [Abstract][Full Text] [Related]
4. Phosphodiesterase inhibitors correct resistance to natriuretic peptides in rats with Heymann Nephritis.
Valentin JP; Ying WZ; Sechi LA; Ling KT; Qiu C; Couser WG; Humphreys MH
J Am Soc Nephrol; 1996 Apr; 7(4):582-93. PubMed ID: 8724892
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of cGMP-phosphodiesterase restores the glomerular effects of atrial natriuretic factor in low sodium diet rats.
Kalinowski L; Szczepanska-Konkel M; Pawelczyk T; Bizon D; Angielski S
Ren Physiol Biochem; 1995; 18(5):254-66. PubMed ID: 8869083
[TBL] [Abstract][Full Text] [Related]
6. Zaprinast accelerates recovery from established acute renal failure in the rat.
Guan Z; Miller SB; Greenwald JE
Kidney Int; 1995 Jun; 47(6):1569-75. PubMed ID: 7643525
[TBL] [Abstract][Full Text] [Related]
7. Increased activity of guanosine 3'-5'-cyclic monophosphate phosphodiesterase in the renal tissue of cirrhotic rats with ascites.
Angeli P; Jiménez W; Veggian R; Fasolato S; Volpin R; MacHenzie HS; Craighero R; Libera VD; Sticca A; Arroyo V; Gatta A
Hepatology; 2000 Feb; 31(2):304-10. PubMed ID: 10655250
[TBL] [Abstract][Full Text] [Related]
8. Nitric oxide synthase and cGMP-mediated stimulation of renin secretion.
Sayago CM; Beierwaltes WH
Am J Physiol Regul Integr Comp Physiol; 2001 Oct; 281(4):R1146-51. PubMed ID: 11557622
[TBL] [Abstract][Full Text] [Related]
9. Effect of increased myocardial cyclic GMP induced by cyclic GMP-phosphodiesterase inhibition on oxygen consumption and supply of rabbit hearts.
Weiss HR; Rodriguez E; Tse J; Scholz PM
Clin Exp Pharmacol Physiol; 1994 Aug; 21(8):607-14. PubMed ID: 7813120
[TBL] [Abstract][Full Text] [Related]
10. Increased cGMP phosphodiesterase activity mediates renal resistance to ANP in rats with bile duct ligation.
Ni XP; Safai M; Gardner DG; Humphreys MH
Kidney Int; 2001 Apr; 59(4):1264-73. PubMed ID: 11260387
[TBL] [Abstract][Full Text] [Related]
11. N omega-nitro-L-arginine attenuates the accumulation of aortic cyclic GMP and the hypotension produced by zaprinast.
Dundore RL; Pratt PF; O'Connor B; Buchholz RA; Pagani ED
Eur J Pharmacol; 1991 Jul; 200(1):83-7. PubMed ID: 1663042
[TBL] [Abstract][Full Text] [Related]
12. Depressor and natriuretic effects of M&B 22,948, a guanosine cyclic 3',5'-monophosphate-selective phosphodiesterase inhibitor.
McMahon EG; Palomo MA; Mehta P; Olins GM
J Pharmacol Exp Ther; 1989 Dec; 251(3):1000-5. PubMed ID: 2557409
[TBL] [Abstract][Full Text] [Related]
13. Zaprinast increases cyclic GMP levels in plasma and in aortic tissue of rats.
Dundore RL; Clas DM; Wheeler LT; Habeeb PG; Bode DC; Buchholz RA; Silver PJ; Pagani ED
Eur J Pharmacol; 1993 Nov; 249(3):293-7. PubMed ID: 8287916
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms contributing to renal resistance to atrial natriuretic peptide in rats with common bile-duct ligation.
Ni X; Cheng Y; Cao L; Gardner DG; Humphreys MH
J Am Soc Nephrol; 1996 Oct; 7(10):2110-8. PubMed ID: 8915970
[TBL] [Abstract][Full Text] [Related]
15. The cGMP phosphodiesterase inhibitor zaprinast enhances the effect of nitric oxide.
Thusu KG; Morin FC; Russell JA; Steinhorn RH
Am J Respir Crit Care Med; 1995 Nov; 152(5 Pt 1):1605-10. PubMed ID: 7582302
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo interactions of nitrovasodilators and zaprinast, a cGMP-selective phosphodiesterase inhibitor.
Merkel LA; Rivera LM; Perrone MH; Lappe RW
Eur J Pharmacol; 1992 May; 216(1):29-35. PubMed ID: 1326438
[TBL] [Abstract][Full Text] [Related]
17. Effects of zaprinast and rolipram on platelet aggregation and arrhythmias following myocardial ischaemia and reperfusion in anaesthetized rabbits.
Holbrook M; Coker SJ
Br J Pharmacol; 1991 Aug; 103(4):1973-9. PubMed ID: 1655149
[TBL] [Abstract][Full Text] [Related]
18. Effects of sodium nitroprusside on renal functions and NO-cGMP production in anesthetized dogs.
Tanahashi M; Sekizawa T; Yoshida M; Suzuki-Kusaba M; Hisa H; Satoh S
J Cardiovasc Pharmacol; 1999 Mar; 33(3):401-8. PubMed ID: 10069675
[TBL] [Abstract][Full Text] [Related]
19. Interaction between nitric oxide and angiotensin II on antidiuresis and norepinephrine overflow induced by stimulation of renal nerves in anesthetized dogs.
Egi Y; Matsumura Y; Miura A; Murata S; Morimoto S
J Cardiovasc Pharmacol; 1995 Feb; 25(2):187-93. PubMed ID: 7752643
[TBL] [Abstract][Full Text] [Related]
20. Renal alpha-adrenoceptors and sodium excretion in the dog.
Fildes RD; Eisner GM; Calcagno PL; Jose PA
Am J Physiol; 1985 Jan; 248(1 Pt 2):F128-33. PubMed ID: 2982274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
